State of Wyoming’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $298K | Buy |
1,962
+494
| +34% | +$75K | 0.04% | 655 |
|
|
2025
Q1 | $221K | Buy |
1,468
+208
| +17% | +$31.3K | 0.03% | 745 |
|
|
2024
Q4 | $233K | Buy |
1,260
+167
| +15% | +$30.8K | 0.03% | 734 |
|
|
2024
Q3 | $215K | Buy |
1,093
+144
| +15% | +$28.4K | 0.03% | 658 |
|
|
2024
Q2 | $196K | Buy |
949
+52
| +6% | +$10.7K | 0.03% | 570 |
|
|
2024
Q1 | $243K | Buy |
897
+186
| +26% | +$50.4K | 0.04% | 474 |
|
|
2023
Q4 | $168K | Buy |
711
+103
| +17% | +$24.3K | 0.03% | 676 |
|
|
2023
Q3 | $119K | Buy |
608
+196
| +48% | +$38.4K | 0.03% | 760 |
|
|
2023
Q2 | $86.6K | Buy |
412
+104
| +34% | +$21.9K | 0.03% | 909 |
|
|
2023
Q1 | $62.2K | Buy |
308
+3
| +1% | +$605 | 0.02% | 1017 |
|
|
2022
Q4 | $66.5K | Sell |
305
-25
| -8% | -$5.45K | 0.02% | 949 |
|
|
2022
Q3 | $65K | Buy |
330
+13
| +4% | +$2.56K | 0.03% | 876 |
|
|
2022
Q2 | $68K | Sell |
317
-57
| -15% | -$12.2K | 0.04% | 745 |
|
|
2022
Q1 | $106K | Sell |
374
-88
| -19% | -$24.9K | 0.05% | 549 |
|
|
2021
Q4 | $174K | Sell |
462
-198
| -30% | -$74.6K | 0.08% | 283 |
|
|
2021
Q3 | $273K | Sell |
660
-95
| -13% | -$39.3K | 0.18% | 97 |
|
|
2021
Q2 | $279K | Buy |
755
+747
| +9,338% | +$276K | 0.18% | 104 |
|
|
2021
Q1 | $2K | Buy |
+8
| New | +$2K | ﹤0.01% | 469 |
|